Salmonella typhimurium A1-R targeting of a chemotherapy resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib-temozlomide
Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 gecko4857
%A Kawaguchi,
%D 2017
%J ABBV Cell Cycle
%K imported
%R 10.1080/15384101.2017.1314420
%T Salmonella typhimurium A1-R targeting of a chemotherapy resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib-temozlomide
@article{gecko4857,
added-at = {2022-03-18T09:41:30.000+0100},
author = {Kawaguchi},
biburl = {https://www.bibsonomy.org/bibtex/2e231974e1c54f4a959fbc7540fe75c4b/nicohell68},
doi = {10.1080/15384101.2017.1314420},
interhash = {df4682e0d824f2a0eacb519b45f92631},
intrahash = {e231974e1c54f4a959fbc7540fe75c4b},
journal = {ABBV Cell Cycle},
keywords = {imported},
timestamp = {2022-03-18T09:41:30.000+0100},
title = {Salmonella typhimurium A1-R targeting of a chemotherapy resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib-temozlomide},
year = 2017
}